---
layout: post
title: "Crohn's Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability"
date: 2026-02-05 18:58:59 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-09240
original_published: 2022-04-29 00:00:00 +0000
significance: 8.00
---

# Crohn's Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** April 29, 2022 00:00 UTC
**Document Number:** 2022-09240

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Crohn's Disease: Developing Drugs for Treatment." This draft guidance addresses FDA's current thinking about necessary attributes of clinical trials for developing drugs for the treatment of Crohn's disease in adults, including recommendations for trial population, trial design, and efficacy and safety considerations.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/04/29/2022-09240/crohns-disease-developing-drugs-for-treatment-draft-guidance-for-industry-availability)
- API: https://www.federalregister.gov/api/v1/documents/2022-09240

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
